{"parse":{"title":"Dual diagnosis","pageid":12391913,"revid":859287289,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">This article is about co-occurring mental disorder and substance abuse. For the general definition of any two diagnoses together, see <a href=\"/wiki/Comorbidity\" title=\"Comorbidity\">Comorbidity</a>.</div>\n<p>\n<b>Dual diagnosis</b> (also called <b>co-occurring disorders</b>, <b>COD</b>, or <b>dual pathology</b>)<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> is the  condition of suffering from a <a href=\"/wiki/Mental_illness\" class=\"mw-redirect\" title=\"Mental illness\">mental illness</a> and a <a href=\"/wiki/Comorbid\" class=\"mw-redirect\" title=\"Comorbid\">comorbid</a> <a href=\"/wiki/Substance_abuse_problem\" class=\"mw-redirect\" title=\"Substance abuse problem\">substance abuse problem</a>.  There is considerable debate surrounding the appropriateness of using a single category for a <a href=\"/wiki/Heterogeneous\" class=\"mw-redirect\" title=\"Heterogeneous\">heterogeneous</a> group of individuals with complex needs and a varied range of problems. The concept can be used broadly, for example depression and alcoholism, or it can be restricted to specify severe mental illness (e.g. <a href=\"/wiki/Psychosis\" title=\"Psychosis\">psychosis</a>, <a href=\"/wiki/Schizophrenia\" title=\"Schizophrenia\">schizophrenia</a>) and substance misuse disorder (e.g. <a href=\"/wiki/Cannabis_abuse\" class=\"mw-redirect\" title=\"Cannabis abuse\">cannabis abuse</a>), or a person who has a milder mental illness and a drug dependency, such as <a href=\"/wiki/Panic_disorder\" title=\"Panic disorder\">panic disorder</a> or <a href=\"/wiki/Generalized_anxiety_disorder\" title=\"Generalized anxiety disorder\">generalized anxiety disorder</a> and is <a href=\"/wiki/Opioid_dependency\" class=\"mw-redirect\" title=\"Opioid dependency\">dependent on opioids</a>.  Diagnosing a primary psychiatric illness in substance abusers is challenging as drug abuse itself often induces psychiatric symptoms, thus making it necessary to differentiate between substance induced and pre-existing mental illness.\n</p><p>Those with co-occurring disorders face complex challenges.  They have increased rates of relapse, hospitalization, <a href=\"/wiki/Homelessness\" title=\"Homelessness\">homelessness</a>, and <a href=\"/wiki/HIV\" title=\"HIV\">HIV</a> and <a href=\"/wiki/Hepatitis_C\" title=\"Hepatitis C\">hepatitis C</a> infection compared to those with either mental or substance use disorders alone.<sup id=\"cite_ref-senate_3-0\" class=\"reference\"><a href=\"#cite_note-senate-3\">&#91;3&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Differentiating_pre-existing_and_substance_induced\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Differentiating pre-existing and substance induced</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Prevalence\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Prevalence</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Diagnosis\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Diagnosis</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Treatment\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Treatment</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Theories_of_dual_diagnosis\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Theories of dual diagnosis</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Causality\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Causality</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Attention-deficit_hyperactivity_disorder\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Attention-deficit hyperactivity disorder</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Autism_spectrum_disorder\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Autism spectrum disorder</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Gambling\"><span class=\"tocnumber\">5.4</span> <span class=\"toctext\">Gambling</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Past_exposure_to_psychiatric_medications_theory\"><span class=\"tocnumber\">5.5</span> <span class=\"toctext\">Past exposure to psychiatric medications theory</span></a></li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Self-medication_theory\"><span class=\"tocnumber\">5.6</span> <span class=\"toctext\">Self-medication theory</span></a></li>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Alleviation_of_dysphoria_theory\"><span class=\"tocnumber\">5.7</span> <span class=\"toctext\">Alleviation of dysphoria theory</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Multiple_risk_factor_theory\"><span class=\"tocnumber\">5.8</span> <span class=\"toctext\">Multiple risk factor theory</span></a></li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#The_supersensitivity_theory\"><span class=\"tocnumber\">5.9</span> <span class=\"toctext\">The supersensitivity theory</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#Avoiding_categorical_diagnosis\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Avoiding categorical diagnosis</span></a></li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#History\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#References\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-18\"><a href=\"#Further_reading\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Further reading</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Differentiating_pre-existing_and_substance_induced\">Differentiating pre-existing and substance induced</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=1\" title=\"Edit section: Differentiating pre-existing and substance induced\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The identification of substance-induced versus independent psychiatric symptoms or disorders has important treatment implications and often constitutes a challenge in daily clinical practice. Similar patterns of comorbidity and risk factors in individuals with substance induced disorder and those with independent non-substance induced psychiatric symptoms suggest that the two conditions may share underlying etiologic factors.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p><p>Drug abuse, including alcohol and prescription drugs, can induce symptomatology which resembles mental illness, which can make it difficult to differentiate between substance induced psychiatric syndromes and pre-existing mental health problems. More often than not psychiatric disorders among drug or alcohol abusers disappear with prolonged abstinence. Substance induced psychiatric symptoms can occur both in the intoxicated state and also during the <a href=\"/wiki/Drug_withdrawal\" title=\"Drug withdrawal\">withdrawal</a> state. In some cases these substance induced psychiatric disorders can persist long after detoxification, such as prolonged psychosis or <a href=\"/wiki/Major_depression\" class=\"mw-redirect\" title=\"Major depression\">depression</a> after amphetamine or cocaine abuse. Abuse of <a href=\"/wiki/Hallucinogens\" class=\"mw-redirect\" title=\"Hallucinogens\">hallucinogens</a> can trigger delusional and other psychotic phenomena long after cessation of use and <a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a> may trigger panic attacks during intoxication and with use it may cause a state similar to <a href=\"/wiki/Dysthymia\" title=\"Dysthymia\">dysthymia</a>. Severe anxiety and depression are commonly induced by sustained alcohol abuse which in most cases abates with prolonged abstinence. Even moderate sustained use of alcohol may increase anxiety and depression levels in some individuals. In most cases these drug induced psychiatric disorders fade away with prolonged abstinence. A <a href=\"/wiki/Protracted_withdrawal_syndrome\" class=\"mw-redirect\" title=\"Protracted withdrawal syndrome\">protracted withdrawal syndrome</a> can also occur with psychiatric and other symptoms persisting for months after cessation of use. Among the currently prevalent medications, <a href=\"/wiki/Benzodiazepines\" class=\"mw-redirect\" title=\"Benzodiazepines\">benzodiazepines</a> are the most notable drug for inducing prolonged withdrawal effects with symptoms sometimes persisting for years after cessation of use.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p><p>Prospective epidemiological studies do not support the hypotheses that comorbidity of substance use disorders with other psychiatric illnesses is primarily a consequence of substance abuse or dependence or that increasing comorbidity is largely attributable to increasing use of substances.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> Yet emphasis is often on the effects of substances on the brain creating the impression that dual disorders are a natural consequence of these substances. However addictive drugs or exposure to gambling will not lead to addictive behaviors or drug dependence in most individuals but only in vulnerable ones, although, according to some researchers, neuroadaptation or regulation of <a href=\"/wiki/Neuronal\" class=\"mw-redirect\" title=\"Neuronal\">neuronal</a> plasticity, and molecular changes, may alter gene expression in some cases and subsequently lead to substance use disorders.\n</p><p>Research instruments are also often insufficiently sensitive to discriminate between independent, true dual pathology, and substance-induced symptoms. Structured instruments, as Global Appraisal of Individual Needs - Short Screener-GAIN-SS and Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV-PRISM,<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> have been developed to increase the diagnostic validity. While structured instruments can help organize diagnostic information, clinicians must still make judgments on the origin of symptoms.\n</p>\n<h2><span class=\"mw-headline\" id=\"Prevalence\">Prevalence</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=2\" title=\"Edit section: Prevalence\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Comorbidity of addictive disorders and other psychiatric disorders, i.e., dual disorders, is very common<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> and a large body of literature has accumulated demonstrating that mental disorders are strongly associated with substance use disorders. The 2011 USA National Survey on Drug Use and Health found that 17.5% of adults with a mental illness had a co-occurring substance use disorder; this works out to 7.98 million people.<sup id=\"cite_ref-SAMHSA_2012_9-0\" class=\"reference\"><a href=\"#cite_note-SAMHSA_2012-9\">&#91;9&#93;</a></sup>  Estimates of co-occurring disorders in Canada are even higher, with an estimated 40-60% of adults with a severe and persistent mental illness experiencing a substance use disorder in their lifetime.<sup id=\"cite_ref-Health_Canada_10-0\" class=\"reference\"><a href=\"#cite_note-Health_Canada-10\">&#91;10&#93;</a></sup>\n</p><p>A study by Kessler et al. in the United States attempting to assess the <a href=\"/wiki/Prevalence\" title=\"Prevalence\">prevalence</a> of dual diagnosis found that 47% of clients with schizophrenia had a substance misuse disorder at some time in their life, and the chances of developing a substance misuse disorder was significantly higher among patients suffering from a psychotic illness than in those without a psychotic illness.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p><p>Another study looked at the extent of substance misuse in a group of 187 chronically mentally ill patients living in the community. According to the clinician's ratings, around a third of the sample used <a href=\"/wiki/Alcoholic_beverage\" class=\"mw-redirect\" title=\"Alcoholic beverage\">alcohol</a>, <a href=\"/wiki/Street_drug\" class=\"mw-redirect\" title=\"Street drug\">street drugs</a>, or both during the six months before evaluation.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p><p>Further UK studies have shown slightly more moderate rates of substance misuse among mentally ill individuals. One study found that individuals suffering from schizophrenia showed just a 7% prevalence of problematic drug use in the year prior to being interviewed and 21% reported problematic use some time before that.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p><p>Wright and colleagues identified individuals with psychotic illnesses who had been in contact with services in the London borough of <a href=\"/wiki/Croydon\" title=\"Croydon\">Croydon</a> over the previous 6 months. Cases of alcohol or substance misuse and dependence were identified through <a href=\"/wiki/Structured_interview\" title=\"Structured interview\">standardized interviews</a> with clients and keyworkers. Results showed that prevalence rates of dual diagnosis were 33% for the use of any substance, 20% for alcohol misuse only and 5% for drug misuse only.<sup class=\"noprint Inline-Template\" style=\"margin-left:0.1em; white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Please_clarify\" title=\"Wikipedia:Please clarify\"><span title=\"Is this current use at the time of the study? (April 2013)\">clarification needed</span></a></i>&#93;</sup> A lifetime history of any illicit drug use was observed in 35% of the sample.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Diagnosis\">Diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=3\" title=\"Edit section: Diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Substance use disorders can be confused with other psychiatric disorders. There are diagnoses for substance-induced mood disorders and substance-induced anxiety disorders and thus such overlap can be complicated. For this reason, the <a href=\"/wiki/DSM-IV\" class=\"mw-redirect\" title=\"DSM-IV\">DSM-IV</a> advises that diagnoses of primary <a href=\"/wiki/Psychiatric\" class=\"mw-redirect\" title=\"Psychiatric\">psychiatric</a> disorders not be made in the absence of <a href=\"/wiki/Sobriety\" title=\"Sobriety\">sobriety</a> (of duration sufficient to allow for any substance-induced <a href=\"/wiki/Post-acute-withdrawal_syndrome\" title=\"Post-acute-withdrawal syndrome\">post-acute-withdrawal</a> symptoms to dissipate) up to 1 year.\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=4\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Only a small proportion of those with co-occurring disorders actually receive treatment for both disorders. Therefore, it was argued that a new approach is needed to enable clinicians, researchers and managers to offer adequate assessment and evidence-based treatments to patients with dual pathology, who cannot be adequately and efficiently managed by cross-referral between psychiatric and addiction services as currently configured and resourced.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup>  In 2011, it was estimated that only 12.4% of American adults with co-occurring disorders were receiving both mental health and addictions treatment.<sup id=\"cite_ref-SAMHSA_2012_9-1\" class=\"reference\"><a href=\"#cite_note-SAMHSA_2012-9\">&#91;9&#93;</a></sup>  Clients with co-occurring disorders face challenges accessing treatment, as they may be excluded from mental health services if they admit to a substance abuse problem, and vice versa.<sup id=\"cite_ref-senate_3-1\" class=\"reference\"><a href=\"#cite_note-senate-3\">&#91;3&#93;</a></sup>\n</p><p>There are multiple approaches to treating concurrent disorders.  Partial treatment involves treating only the disorder that is considered primary.  Sequential treatment involves treating the primary disorder first, and then treating the secondary disorder after the primary disorder has been stabilized.  Parallel treatment involves the client receiving mental health services from one provider, and addictions services from another.<sup id=\"cite_ref-senate_3-2\" class=\"reference\"><a href=\"#cite_note-senate-3\">&#91;3&#93;</a></sup>\n</p><p>Integrated treatment involves a seamless blending of interventions into a single coherent treatment package developed with a consistent philosophy and approach among care providers.<sup id=\"cite_ref-Drake_17-0\" class=\"reference\"><a href=\"#cite_note-Drake-17\">&#91;17&#93;</a></sup><sup id=\"cite_ref-Sciacca_18-0\" class=\"reference\"><a href=\"#cite_note-Sciacca-18\">&#91;18&#93;</a></sup> With this approach, both disorders are considered primary.<sup id=\"cite_ref-SAMHSA_COCE_19-0\" class=\"reference\"><a href=\"#cite_note-SAMHSA_COCE-19\">&#91;19&#93;</a></sup>  Integrated treatment can improve accessibility, service individualization, engagement in treatment, treatment compliance, mental health symptoms, and overall outcomes.<sup id=\"cite_ref-APA_20-0\" class=\"reference\"><a href=\"#cite_note-APA-20\">&#91;20&#93;</a></sup><sup id=\"cite_ref-Rush_21-0\" class=\"reference\"><a href=\"#cite_note-Rush-21\">&#91;21&#93;</a></sup>  The Substance Abuse and Mental Health Services Administration in the United States describes integrated treatment as being in the best interests or clients, programs, funders, and systems.<sup id=\"cite_ref-SAMHSA_COCE_19-1\" class=\"reference\"><a href=\"#cite_note-SAMHSA_COCE-19\">&#91;19&#93;</a></sup>  Green suggested that treatment should be integrated, and a collaborative process between the treatment team and the patient.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> Furthermore, recovery should to be viewed as a marathon rather than a sprint, and methods and outcome goals should be explicit.\n</p><p>Although many patients may reject medications as antithetical to substance-abuse recovery and side effects, they can be useful to reduce paranoia, anxiety, and craving.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (November 2012)\">citation needed</span></a></i>&#93;</sup> Medications that have proven effective include opioid replacement therapies, such as lifelong maintenance on methadone or buprenorphine, to minimize risk of relapse, fatality, and legal trouble amongst opioid addicts, as well as helping with cravings, <a href=\"/wiki/Baclofen\" title=\"Baclofen\">baclofen</a> for alcoholics, opioid addicts, cocaine addicts, and amphetamine addicts, to help eliminate drug cravings, and <a href=\"/wiki/Clozapine\" title=\"Clozapine\">clozapine</a>, the first atypical <a href=\"/wiki/Antipsychotic\" title=\"Antipsychotic\">antipsychotic</a>, which appears to reduce illicit drug use amongst stimulant addicts.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (November 2012)\">citation needed</span></a></i>&#93;</sup> Clozapine can cause respiratory arrest when combined with alcohol, benzodiazepines, or opioids, so it is not recommended to use in these groups.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (November 2012)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Theories_of_dual_diagnosis\">Theories of dual diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=5\" title=\"Edit section: Theories of dual diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>There are a number of theories that explain the relationship between mental illness and substance abuse.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Causality\">Causality</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=6\" title=\"Edit section: Causality\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The causality theory suggests that certain types of substance abuse may causally lead to mental illness.\n</p><p>There is strong evidence that using <a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a> can produce <a href=\"/wiki/Psychosis\" title=\"Psychosis\">psychotic</a> and <a href=\"/wiki/Mood_disorder\" title=\"Mood disorder\">affective experiences</a>.<sup id=\"cite_ref-Moore_24-0\" class=\"reference\"><a href=\"#cite_note-Moore-24\">&#91;24&#93;</a></sup> When it comes to persisting effects, there is a clear increase in incidence of psychotic outcomes in people who had used cannabis, even when they had used it only once. More frequent use of cannabis strongly augmented the risk for psychosis. The evidence for affective outcomes is less strong.<sup id=\"cite_ref-Moore_24-1\" class=\"reference\"><a href=\"#cite_note-Moore-24\">&#91;24&#93;</a></sup> However, this connection between cannabis and psychosis does not prove that cannabis <i>causes</i> psychotic disorders.<sup id=\"cite_ref-Moore_24-2\" class=\"reference\"><a href=\"#cite_note-Moore-24\">&#91;24&#93;</a></sup> The causality theory for cannabis has been challenged as despite explosive increases in cannabis consumption over the past 40 years in western society, the rate of schizophrenia (and psychosis in general) has remained relatively stable.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup><sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup><sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Attention-deficit_hyperactivity_disorder\">Attention-deficit hyperactivity disorder</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=7\" title=\"Edit section: Attention-deficit hyperactivity disorder\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>One in four people who have a substance use disorder also have <a href=\"/wiki/Attention-deficit_hyperactivity_disorder\" class=\"mw-redirect\" title=\"Attention-deficit hyperactivity disorder\">attention-deficit hyperactivity disorder</a>,<sup id=\"cite_ref-van_Emmerik-van_Oortmerssen-2012_28-0\" class=\"reference\"><a href=\"#cite_note-van_Emmerik-van_Oortmerssen-2012-28\">&#91;28&#93;</a></sup> which makes the treatment of both conditions more difficult. ADHD is associated with an increased craving for drugs.<sup id=\"cite_ref-Frodl-2010_29-0\" class=\"reference\"><a href=\"#cite_note-Frodl-2010-29\">&#91;29&#93;</a></sup> Having ADHD makes it more likely that an individual will initiate substance misuse at a younger age than their peers.<sup id=\"cite_ref-Upadhyaya-2007_30-0\" class=\"reference\"><a href=\"#cite_note-Upadhyaya-2007-30\">&#91;30&#93;</a></sup> They are also more likely to have a poorer outcome, such as longer time to remission, and increased psychiatric complications from substance misuse.<sup id=\"cite_ref-Frodl-2010_29-1\" class=\"reference\"><a href=\"#cite_note-Frodl-2010-29\">&#91;29&#93;</a></sup><sup id=\"cite_ref-Upadhyaya-2007_30-1\" class=\"reference\"><a href=\"#cite_note-Upadhyaya-2007-30\">&#91;30&#93;</a></sup>  While generally stimulant medications do not seem to worsen substance misuse, they are known to be abused in some cases. Psychosocial therapy and/or nonstimulant medications and extended release stimulants are ADHD treatment options that reduce these risks.<sup id=\"cite_ref-Upadhyaya-2007_30-2\" class=\"reference\"><a href=\"#cite_note-Upadhyaya-2007-30\">&#91;30&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Autism_spectrum_disorder\">Autism spectrum disorder</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=8\" title=\"Edit section: Autism spectrum disorder\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Unlike ADHD, which significantly increases the risk of substance use disorder, autism spectrum disorder has the opposite effect of significantly reducing the risk of substance abuse. This is because introversion, inhibition and lack of sensation seeking personality traits, which are typical of autism spectrum disorder, protect against substance abuse and thus substance abuse levels are low in individuals who are on the  autism spectrum.<sup id=\"cite_ref-Ramos-2013_31-0\" class=\"reference\"><a href=\"#cite_note-Ramos-2013-31\">&#91;31&#93;</a></sup> However, certain forms of substance abuse, especially alcohol abuse, can cause or worsen certain neuropsychological symptoms which are common to autism spectrum disorder, such as impaired <a href=\"/wiki/Social_skills\" title=\"Social skills\">social skills</a> due to the neurotoxic effects of alcohol on the brain, especially the <a href=\"/wiki/Prefrontal_cortex\" title=\"Prefrontal cortex\">prefrontal cortex</a> area of the brain. The social skills that are impaired by <a href=\"/wiki/Alcohol_abuse\" title=\"Alcohol abuse\">alcohol abuse</a> include impairments in perceiving facial emotions, prosody perception problems and <a href=\"/wiki/Theory_of_mind\" title=\"Theory of mind\">theory of mind</a> deficits; the ability to understand humour is also impaired in alcohol abusers.<sup id=\"cite_ref-pmid18412750_32-0\" class=\"reference\"><a href=\"#cite_note-pmid18412750-32\">&#91;32&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Gambling\">Gambling</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=9\" title=\"Edit section: Gambling\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The inclusion of behavioral addictions like pathological gambling must change our way of understanding and dealing with addictions. Pathological (disordered) gambling has commonalities in clinical expression, etiology, comorbidity, physiology and treatment with substance use disorders (DSM-5). A challenge is to understand the development of compulsivity at a neurochemical level not only for drugs.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Past_exposure_to_psychiatric_medications_theory\">Past exposure to psychiatric medications theory</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=10\" title=\"Edit section: Past exposure to psychiatric medications theory\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The past exposure theory suggests that <a href=\"/wiki/Exposure_to_toxins\" class=\"mw-redirect\" title=\"Exposure to toxins\">exposure</a> to psychiatric medication alters neural <a href=\"/wiki/Synapses\" class=\"mw-redirect\" title=\"Synapses\">synapses</a>, introducing an <a href=\"https://en.wiktionary.org/wiki/imbalance\" class=\"extiw\" title=\"wikt:imbalance\">imbalance</a> that was not previously present.  Discontinuation of the drug is expected to result in symptoms of psychiatric illness which resolve once the drug is restarted.<sup id=\"cite_ref-robertwhitaker.org_34-0\" class=\"reference\"><a href=\"#cite_note-robertwhitaker.org-34\">&#91;34&#93;</a></sup> This theory suggests that while it may appear that the medication is working, it is only treating a disorder caused by the medication itself.<sup id=\"cite_ref-robertwhitaker.org_34-1\" class=\"reference\"><a href=\"#cite_note-robertwhitaker.org-34\">&#91;34&#93;</a></sup> New exposure to psychiatric medication may lead to heightened sensitivity to the effects of drugs and alcohol, which has a deteriorating effect on the patient.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup><sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup><sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Self-medication_theory\">Self-medication theory</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=11\" title=\"Edit section: Self-medication theory\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The <a href=\"/wiki/Self-medication\" title=\"Self-medication\">self-medication</a> theory suggests that people with severe mental illnesses misuse substances in order to relieve a specific set of symptoms and counter the negative side-effects of <a href=\"/wiki/Antipsychotic\" title=\"Antipsychotic\">antipsychotic medication</a>.<sup id=\"cite_ref-Khantzian_39-0\" class=\"reference\"><a href=\"#cite_note-Khantzian-39\">&#91;39&#93;</a></sup>\n</p><p>Khantizan proposes that substances are not randomly chosen, but are specifically selected for their effects. For example, using stimulants such as <a href=\"/wiki/Nicotine\" title=\"Nicotine\">nicotine</a> or <a href=\"/wiki/Amphetamine\" title=\"Amphetamine\">amphetamines</a> can be used to combat the <a href=\"/wiki/Sedation\" title=\"Sedation\">sedation</a> that can be caused by higher doses of certain types of antipsychotic medication.<sup id=\"cite_ref-Khantzian_39-1\" class=\"reference\"><a href=\"#cite_note-Khantzian-39\">&#91;39&#93;</a></sup> Conversely, some people taking medications with a <a href=\"/wiki/Stimulant\" title=\"Stimulant\">stimulant</a> effect such as the <a href=\"/wiki/Serotonin-norepinephrine_reuptake_inhibitor\" class=\"mw-redirect\" title=\"Serotonin-norepinephrine reuptake inhibitor\">SNRI</a> antidepressants Effexor (<a href=\"/wiki/Venlafaxine\" title=\"Venlafaxine\">venlafaxine</a>) or Wellbutrin (<a href=\"/wiki/Bupropion\" title=\"Bupropion\">bupropion</a>) may seek out <a href=\"/wiki/Benzodiazepines\" class=\"mw-redirect\" title=\"Benzodiazepines\">benzodiazepines</a> or <a href=\"/wiki/Opioid\" title=\"Opioid\">opioid</a> <a href=\"/wiki/Narcotics\" class=\"mw-redirect\" title=\"Narcotics\">narcotics</a> to counter the <a href=\"/wiki/Anxiety\" title=\"Anxiety\">anxiety</a> and <a href=\"/wiki/Insomnia\" title=\"Insomnia\">insomnia</a> that such medications sometimes evoke.\n</p><p>Some studies show that nicotine administration can be effective for reducing motor side-effects of antipsychotics, with both <a href=\"/wiki/Bradykinesia\" class=\"mw-redirect\" title=\"Bradykinesia\">bradykinesia</a><sup id=\"cite_ref-pmid12377405_40-0\" class=\"reference\"><a href=\"#cite_note-pmid12377405-40\">&#91;40&#93;</a></sup> (stiff muscles) and <a href=\"/wiki/Dyskinesia\" title=\"Dyskinesia\">dyskinesia</a><sup id=\"cite_ref-pmid15008806_41-0\" class=\"reference\"><a href=\"#cite_note-pmid15008806-41\">&#91;41&#93;</a></sup>(involuntary movement) being prevented.\n</p>\n<h3><span class=\"mw-headline\" id=\"Alleviation_of_dysphoria_theory\">Alleviation of dysphoria theory</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=12\" title=\"Edit section: Alleviation of dysphoria theory\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The alleviation of <a href=\"/wiki/Dysphoria\" title=\"Dysphoria\">dysphoria</a> theory suggests that people with severe mental illness commonly have a negative <a href=\"/wiki/Self-image\" title=\"Self-image\">self-image</a>, which makes them vulnerable to using <a href=\"/wiki/Psychoactive_drug\" title=\"Psychoactive drug\">psychoactive substances</a> to alleviate these feelings. Despite the existence of a wide range of dysphoric feelings (<a href=\"/wiki/Anxiety\" title=\"Anxiety\">anxiety</a>, depression, <a href=\"/wiki/Boredom\" title=\"Boredom\">boredom</a>, and <a href=\"/wiki/Loneliness\" title=\"Loneliness\">loneliness</a>), the literature on self-reported reasons for use seems to lend support for the experience of these feelings being the primary motivator for drug and alcohol misuse.<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Multiple_risk_factor_theory\">Multiple risk factor theory</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=13\" title=\"Edit section: Multiple risk factor theory\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Another theory is that there may be shared risk factors that can lead to both substance abuse and mental illness. Mueser hypothesizes that these may include factors such as <a href=\"/wiki/Social_isolation\" title=\"Social isolation\">social isolation</a>, poverty, lack of structured daily activity, lack of adult role responsibility, living in areas with high drug availability, and association with people who already misuse drugs.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup><sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup>\n</p><p>Other evidence suggests that <a href=\"/wiki/Psychological_trauma\" title=\"Psychological trauma\">traumatic</a> life events, such as sexual <a href=\"/wiki/Abuse\" title=\"Abuse\">abuse</a>, are associated with the development of psychiatric problems and substance abuse.<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"The_supersensitivity_theory\">The supersensitivity theory</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=14\" title=\"Edit section: The supersensitivity theory\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The supersensitivity theory<sup id=\"cite_ref-mueser_AB_46-0\" class=\"reference\"><a href=\"#cite_note-mueser_AB-46\">&#91;46&#93;</a></sup> proposes that certain individuals who have severe mental illness also have biological and psychological vulnerabilities, caused by genetic and early <a href=\"/wiki/Environment_(biophysical)\" class=\"mw-redirect\" title=\"Environment (biophysical)\">environmental</a> life events.  These interact with stressful life events and can result in either a psychiatric disorder or trigger a relapse into an existing illness. The theory states that although anti-psychotic medication can reduce the vulnerability, substance abuse may increase it, causing the individual to be more likely to experience negative consequences from using relatively small amounts of substances.  These individuals, therefore, are \"supersensitive\" to the effects of certain substances, and individuals with psychotic illness such as schizophrenia may be less capable of sustaining moderate substance use over time without experiencing negative symptoms.\n</p><p>Although there are limitations in the research studies conducted in this area, namely that most have focused primarily on schizophrenia, this theory provides an explanation of why relatively low levels of substance misuse often result in negative consequences for individuals with severe mental illness.<sup id=\"cite_ref-mueser_AB_46-1\" class=\"reference\"><a href=\"#cite_note-mueser_AB-46\">&#91;46&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Avoiding_categorical_diagnosis\">Avoiding categorical diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=15\" title=\"Edit section: Avoiding categorical diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Current nosological approach does not provide a framework for internal (sub-threshold symptoms) or external (comorbidity) heterogeneity of the different <a href=\"/wiki/Diagnostic\" class=\"mw-redirect\" title=\"Diagnostic\">diagnostic</a> categories.<sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup> The prevailing \"Neo-Kraepelinian\" diagnostic system solely accounts for a categorical diagnosis, therefore not allowing for the possibility of dual diagnosis. There has been substantial criticism to the <i><a href=\"/wiki/Diagnostic_and_Statistical_Manual_of_Mental_Disorders\" title=\"Diagnostic and Statistical Manual of Mental Disorders\">Diagnostic and Statistical Manual of Mental Disorders</a></i> (DSM-IV), due to problems of diagnostic overlap, lack of clear boundaries between normality and <a href=\"/wiki/Disease\" title=\"Disease\">disease</a>, a failure to take into account findings from novel research and the lack of diagnostic stability over time.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=16\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The traditional method for treating patients suffering from dual diagnosis was a parallel treatment program.<sup id=\"cite_ref-Drake_1998_49-0\" class=\"reference\"><a href=\"#cite_note-Drake_1998-49\">&#91;49&#93;</a></sup> In this format, patients received mental health services from one clinician while addressing their substance abuse with a separate clinician.<sup id=\"cite_ref-Drake_1998_49-1\" class=\"reference\"><a href=\"#cite_note-Drake_1998-49\">&#91;49&#93;</a></sup> However, researchers found that parallel treatments were ineffective, suggesting a need to integrate the services addressing mental health with those addressing substance abuse.<sup id=\"cite_ref-Drake_2000_50-0\" class=\"reference\"><a href=\"#cite_note-Drake_2000-50\">&#91;50&#93;</a></sup>\n</p><p>During the mid-1980s, a number of initiatives began to combine mental health and substance abuse services in an attempt to meet this need.<sup id=\"cite_ref-51\" class=\"reference\"><a href=\"#cite_note-51\">&#91;51&#93;</a></sup><sup id=\"cite_ref-Drake_2001_52-0\" class=\"reference\"><a href=\"#cite_note-Drake_2001-52\">&#91;52&#93;</a></sup><sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup> These programs worked to shift the method of treatment for substance abuse from a confrontational approach to a supportive one.<sup id=\"cite_ref-54\" class=\"reference\"><a href=\"#cite_note-54\">&#91;54&#93;</a></sup> They also introduced new methods to motivate clients and worked with them to develop long-term goals for their care.<sup id=\"cite_ref-Drake_2001_52-1\" class=\"reference\"><a href=\"#cite_note-Drake_2001-52\">&#91;52&#93;</a></sup> Although the studies conducted by these initiatives did not have control groups, their results were promising and became the basis for more rigorous efforts to study and develop models of integrated treatment.<sup id=\"cite_ref-Drake_2001_52-2\" class=\"reference\"><a href=\"#cite_note-Drake_2001-52\">&#91;52&#93;</a></sup><sup id=\"cite_ref-55\" class=\"reference\"><a href=\"#cite_note-55\">&#91;55&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=17\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.samhsa.gov/reports/congress2002/chap1ucod.htm\">\"Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders\"</a>. <a href=\"/wiki/SAMHSA\" class=\"mw-redirect\" title=\"SAMHSA\">SAMHSA</a>. November 2001<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 May</span> 2012</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Report+to+Congress+on+the+prevention+and+treatment+of+co-occurring+substance+abuse+disorders+and+mental+disorders&amp;rft.pub=SAMHSA&amp;rft.date=2001-11&amp;rft_id=http%3A%2F%2Fwww.samhsa.gov%2Freports%2Fcongress2002%2Fchap1ucod.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\">Casas M. Trastornos duales. Vallejo Ruiloba J, Gast\u00f3 Ferrer C (eds). Trastornos afectivos: ansiedad y depresi\u00f3n (2\u00aa ed). Barcelona, Masson; 2000:890-899.</span>\n</li>\n<li id=\"cite_note-senate-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-senate_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-senate_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-senate_3-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Standing Senate Committee on Social Affairs, Science, and Technology (2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.parl.gc.ca/Content/SEN/Committe/391/soci/rep/pdf/rep02may06part1-e.pdf\">\"Out of the Shadows at Last: Transforming Mental Health, Mental Illness and Addictions Services in Canada\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Government of Canada<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 April</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Out+of+the+Shadows+at+Last%3A+Transforming+Mental+Health%2C+Mental+Illness+and+Addictions+Services+in+Canada&amp;rft.pub=Government+of+Canada&amp;rft.date=2006&amp;rft.au=Standing+Senate+Committee+on+Social+Affairs%2C+Science%2C+and+Technology&amp;rft_id=http%3A%2F%2Fwww.parl.gc.ca%2FContent%2FSEN%2FCommitte%2F391%2Fsoci%2Frep%2Fpdf%2Frep02may06part1-e.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\">Blanco 2012 p. 865-873.</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Evans, Katie; Sullivan, Michael J. (1 March 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=lvUzR0obihEC\"><i>Dual Diagnosis: Counseling the Mentally Ill Substance Abuser</i></a> (2nd ed.). Guilford Press. pp.&#160;75\u201376. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-57230-446-8\" title=\"Special:BookSources/978-1-57230-446-8\">978-1-57230-446-8</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Dual+Diagnosis%3A+Counseling+the+Mentally+Ill+Substance+Abuser&amp;rft.pages=75-76&amp;rft.edition=2nd&amp;rft.pub=Guilford+Press&amp;rft.date=2001-03-01&amp;rft.isbn=978-1-57230-446-8&amp;rft.aulast=Evans&amp;rft.aufirst=Katie&amp;rft.au=Sullivan%2C+Michael+J.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DlvUzR0obihEC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\">Frisher 2005 p. 847-850.</span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\">Hasin 2006 p. 689-696</span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\">Adamson 2006 p. 164-170; Hasin et al, 2011</span>\n</li>\n<li id=\"cite_note-SAMHSA_2012-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SAMHSA_2012_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SAMHSA_2012_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Substance Abuse and Mental Health Services Administration (2012). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.samhsa.gov/data/NSDUH/2k11MH_FindingsandDetTables/2K11MHFR/NSDUHmhfr2011.htm\">\"Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 April</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Results+from+the+2011+National+Survey+on+Drug+Use+and+Health%3A+Mental+Health+Findings&amp;rft.date=2012&amp;rft.au=Substance+Abuse+and+Mental+Health+Services+Administration&amp;rft_id=http%3A%2F%2Fwww.samhsa.gov%2Fdata%2FNSDUH%2F2k11MH_FindingsandDetTables%2F2K11MHFR%2FNSDUHmhfr2011.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Health_Canada-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Health_Canada_10-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Health Canada (2012). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/pubs/adp-apd/bp_disorder-mp_concomitants/bp_concurrent_mental_health-eng.pdf\">\"Best Practices: Concurrent Mental Health and Substance Use Disorders\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Government of Canada<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 April</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Best+Practices%3A+Concurrent+Mental+Health+and+Substance+Use+Disorders&amp;rft.pub=Government+of+Canada&amp;rft.date=2012&amp;rft.au=Health+Canada&amp;rft_id=http%3A%2F%2Fwww.hc-sc.gc.ca%2Fhc-ps%2Falt_formats%2Fhecs-sesc%2Fpdf%2Fpubs%2Fadp-apd%2Fbp_disorder-mp_concomitants%2Fbp_concurrent_mental_health-eng.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kessler RC; McGonagle KA; Zhao S; Nelson CB; Hughes M; Eshleman S; Wittchen HU; Kendler KS (1994). \"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey\". <i><a href=\"/wiki/Archives_of_General_Psychiatry\" class=\"mw-redirect\" title=\"Archives of General Psychiatry\">Archives of General Psychiatry</a></i>. <b>51</b> (1): 8\u201319. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archpsyc.1994.03950010008002\">10.1001/archpsyc.1994.03950010008002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8279933\">8279933</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.atitle=Lifetime+and+12-month+prevalence+of+DSM-III-R+psychiatric+disorders+in+the+United+States.+Results+from+the+National+Comorbidity+Survey&amp;rft.volume=51&amp;rft.issue=1&amp;rft.pages=8-19&amp;rft.date=1994&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.1994.03950010008002&amp;rft_id=info%3Apmid%2F8279933&amp;rft.au=Kessler+RC&amp;rft.au=McGonagle+KA&amp;rft.au=Zhao+S&amp;rft.au=Nelson+CB&amp;rft.au=Hughes+M&amp;rft.au=Eshleman+S&amp;rft.au=Wittchen+HU&amp;rft.au=Kendler+KS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Regier DA; Farmer ME; Rae DS; Locke BZ; Keith SJ; Judd LL; Goodwin FK (1990). \"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study\". <i><a href=\"/wiki/Journal_of_the_American_Medical_Association\" class=\"mw-redirect\" title=\"Journal of the American Medical Association\">JAMA</a></i>. <b>264</b> (19): 2511\u201318. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.264.19.2511\">10.1001/jama.264.19.2511</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2232018\">2232018</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Comorbidity+of+mental+disorders+with+alcohol+and+other+drug+abuse.+Results+from+the+Epidemiologic+Catchment+Area+%28ECA%29+Study&amp;rft.volume=264&amp;rft.issue=19&amp;rft.pages=2511-18&amp;rft.date=1990&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.264.19.2511&amp;rft_id=info%3Apmid%2F2232018&amp;rft.au=Regier+DA&amp;rft.au=Farmer+ME&amp;rft.au=Rae+DS&amp;rft.au=Locke+BZ&amp;rft.au=Keith+SJ&amp;rft.au=Judd+LL&amp;rft.au=Goodwin+FK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Drake RE; Wallach MA (1993). \"Moderate drinking among people with severe mental illness\". <i>Hospital &amp; Community Psychiatry</i>. <b>44</b> (8): 780\u20132. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8375841\">8375841</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hospital+%26+Community+Psychiatry&amp;rft.atitle=Moderate+drinking+among+people+with+severe+mental+illness&amp;rft.volume=44&amp;rft.issue=8&amp;rft.pages=780-2&amp;rft.date=1993&amp;rft_id=info%3Apmid%2F8375841&amp;rft.au=Drake+RE&amp;rft.au=Wallach+MA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cantwell, R; Scottish Comorbidity Study Group (2003). <a rel=\"nofollow\" class=\"external text\" href=\"http://bjp.rcpsych.org/cgi/content/full/182/4/324\">\"Substance use and schizophrenia: effects on symptoms, social functioning and service use\"</a>. <i><a href=\"/wiki/British_Journal_of_Psychiatry\" title=\"British Journal of Psychiatry\">British Journal of Psychiatry</a></i>. <b>182</b> (4): 324\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1192/bjp.182.4.324\">10.1192/bjp.182.4.324</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12668408\">12668408</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 February</span> 2008</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Psychiatry&amp;rft.atitle=Substance+use+and+schizophrenia%3A+effects+on+symptoms%2C+social+functioning+and+service+use&amp;rft.volume=182&amp;rft.issue=4&amp;rft.pages=324-9&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.182.4.324&amp;rft_id=info%3Apmid%2F12668408&amp;rft.aulast=Cantwell&amp;rft.aufirst=R&amp;rft.au=Scottish+Comorbidity+Study+Group&amp;rft_id=http%3A%2F%2Fbjp.rcpsych.org%2Fcgi%2Fcontent%2Ffull%2F182%2F4%2F324&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wright S; Gournay K; Glorney E; Thornicroft G (2000). \"Dual diagnosis in the suburbs: prevalence, need, and in-patient service use\". <i><a href=\"/wiki/Social_Psychiatry_%26_Psychiatric_Epidemiology\" class=\"mw-redirect\" title=\"Social Psychiatry &amp; Psychiatric Epidemiology\">Social Psychiatry &amp; Psychiatric Epidemiology</a></i>. <b>35</b> (7): 297\u2013304. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s001270050242\">10.1007/s001270050242</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11016524\">11016524</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Social+Psychiatry+%26+Psychiatric+Epidemiology&amp;rft.atitle=Dual+diagnosis+in+the+suburbs%3A+prevalence%2C+need%2C+and+in-patient+service+use&amp;rft.volume=35&amp;rft.issue=7&amp;rft.pages=297-304&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1007%2Fs001270050242&amp;rft_id=info%3Apmid%2F11016524&amp;rft.au=Wright+S&amp;rft.au=Gournay+K&amp;rft.au=Glorney+E&amp;rft.au=Thornicroft+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Weaver T, Madden P, Charles V;  et al. (2003). \"Comorbidity of substance misuse and mental illness in community mental health and substance misuse services\". <i>Br J Psychiatry</i>. <b>183</b>: 304\u2013313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1192/bjp.183.4.304\">10.1192/bjp.183.4.304</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br+J+Psychiatry&amp;rft.atitle=Comorbidity+of+substance+misuse+and+mental+illness+in+community+mental+health+and+substance+misuse+services&amp;rft.volume=183&amp;rft.pages=304-313&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.183.4.304&amp;rft.au=Weaver+T%2C+Madden+P%2C+Charles+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Explicit use of et al. (<a href=\"/wiki/Category:CS1_maint:_Explicit_use_of_et_al.\" title=\"Category:CS1 maint: Explicit use of et al.\">link</a>) CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-Drake-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Drake_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Drake RE Mueser KT Brunette MR McHugo GJ (2004). \"A Review of Treatments for People with Severe Mental Illness and Co-Occurring Substance Use Disorders\". <i>Psychiatric Rehabilitation Journal</i>. <b>27</b> (4): 360\u2013374. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2975/27.2004.360.374\">10.2975/27.2004.360.374</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatric+Rehabilitation+Journal&amp;rft.atitle=A+Review+of+Treatments+for+People+with+Severe+Mental+Illness+and+Co-Occurring+Substance+Use+Disorders&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=360-374&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.2975%2F27.2004.360.374&amp;rft.au=Drake+RE+Mueser+KT+Brunette+MR+McHugo+GJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sciacca-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Sciacca_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sciacca, K (2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/21801032/BestPracticesForDualDiagnosisTreatment-ProgramDevelopment-Co-occurring-Mental-Illness-Substance-Disorders-Kathleen-Sciacca-2009\">\"Best Practices for Dual Diagnosis Treatment and Program Development: Co-occurring Mental Illness and Substance Disorders in Various Combinations\"</a>. <i>The Praeger International Collection on Addictions, Editor, Angela Brown-Miller, Vol. 3, Chapter 9, Pgs. 161-188, Praeger, Westport, CT. London</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Praeger+International+Collection+on+Addictions%2C+Editor%2C+Angela+Brown-Miller%2C+Vol.+3%2C+Chapter+9%2C+Pgs.+161-188%2C+Praeger%2C+Westport%2C+CT.+London.&amp;rft.atitle=Best+Practices+for+Dual+Diagnosis+Treatment+and+Program+Development%3A+Co-occurring+Mental+Illness+and+Substance+Disorders+in+Various+Combinations&amp;rft.date=2009&amp;rft.aulast=Sciacca&amp;rft.aufirst=K&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F21801032%2FBestPracticesForDualDiagnosisTreatment-ProgramDevelopment-Co-occurring-Mental-Illness-Substance-Disorders-Kathleen-Sciacca-2009&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SAMHSA_COCE-19\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SAMHSA_COCE_19-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SAMHSA_COCE_19-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Center for Co-Occurring Disorders (2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20141006081559/http://store.samhsa.gov/shin/content//PHD1132/PHD1132.pdf\">\"Overarching Principles to Address the Needs of Persons with Co-Occurring Disorders\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Substance and Mental Health Services Administration. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://store.samhsa.gov/shin/content//PHD1132/PHD1132.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 6 October 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 April</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Overarching+Principles+to+Address+the+Needs+of+Persons+with+Co-Occurring+Disorders&amp;rft.pub=Substance+and+Mental+Health+Services+Administration&amp;rft.date=2006&amp;rft.au=Center+for+Co-Occurring+Disorders&amp;rft_id=http%3A%2F%2Fstore.samhsa.gov%2Fshin%2Fcontent%2F%2FPHD1132%2FPHD1132.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-APA-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-APA_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">American Psychiatric Association (2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://psychiatryonline.org/content.aspx?bookid=28&amp;sectionid=1675010\">\"Practice Guidelines for the Treatment of Patients with Substance Use Disorders, 2nd ed\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 April</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Practice+Guidelines+for+the+Treatment+of+Patients+with+Substance+Use+Disorders%2C+2nd+ed&amp;rft.date=2006&amp;rft.au=American+Psychiatric+Association&amp;rft_id=http%3A%2F%2Fpsychiatryonline.org%2Fcontent.aspx%3Fbookid%3D28%26sectionid%3D1675010&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Rush-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Rush_21-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Rush B Fobb B Nadeau L Furlong A (2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ccsa.ca/ceca/pdf/Main-reportFINALa.pdf\">\"On the Intregation of Mental Health and Substance Use Services and Systems: Main Report\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Canadian Executive Council on Addictions<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 April</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=On+the+Intregation+of+Mental+Health+and+Substance+Use+Services+and+Systems%3A+Main+Report&amp;rft.pub=Canadian+Executive+Council+on+Addictions&amp;rft.date=2008&amp;rft.au=Rush+B+Fobb+B+Nadeau+L+Furlong+A&amp;rft_id=http%3A%2F%2Fwww.ccsa.ca%2Fceca%2Fpdf%2FMain-reportFINALa.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Green MD (19 March 2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.psychiatrictimes.com/paranoia/article/10168/1390341\">\"Development of a Dual Disorders Program Methodology for Better Outcomes\"</a>. <i>Psychiatric Times</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatric+Times&amp;rft.atitle=Development+of+a+Dual+Disorders+Program+Methodology+for+Better+Outcomes&amp;rft.date=2009-03-19&amp;rft.au=Green+MD&amp;rft_id=http%3A%2F%2Fwww.psychiatrictimes.com%2Fparanoia%2Farticle%2F10168%2F1390341&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mueser KT; Essock SM; Drake RE; Wolfe RS; Frisman L (2001). \"Rural and urban differences in patients with a dual diagnosis\". <i><a href=\"/wiki/Schizophrenia_Research\" title=\"Schizophrenia Research\">Schizophrenia Research</a></i>. <b>48</b> (1): 93\u2013107. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0920-9964%2800%2900065-7\">10.1016/S0920-9964(00)00065-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11278157\">11278157</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Research&amp;rft.atitle=Rural+and+urban+differences+in+patients+with+a+dual+diagnosis&amp;rft.volume=48&amp;rft.issue=1&amp;rft.pages=93-107&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1016%2FS0920-9964%2800%2900065-7&amp;rft_id=info%3Apmid%2F11278157&amp;rft.au=Mueser+KT&amp;rft.au=Essock+SM&amp;rft.au=Drake+RE&amp;rft.au=Wolfe+RS&amp;rft.au=Frisman+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Moore-24\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Moore_24-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Moore_24-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Moore_24-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Moore TH; Zammit S; Lingford-Hughes A; Barnes TR; Jones PB; Burke M; Lewis G (2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bris.ac.uk/psychiatry/staff/zammit/documents/paper.pdf\">\"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i><a href=\"/wiki/The_Lancet\" title=\"The Lancet\">The Lancet</a></i>. <b>370</b> (9584): 319\u201328. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2807%2961162-3\">10.1016/S0140-6736(07)61162-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17662880\">17662880</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Cannabis+use+and+risk+of+psychotic+or+affective+mental+health+outcomes%3A+a+systematic+review&amp;rft.volume=370&amp;rft.issue=9584&amp;rft.pages=319-28&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2807%2961162-3&amp;rft_id=info%3Apmid%2F17662880&amp;rft.au=Moore+TH&amp;rft.au=Zammit+S&amp;rft.au=Lingford-Hughes+A&amp;rft.au=Barnes+TR&amp;rft.au=Jones+PB&amp;rft.au=Burke+M&amp;rft.au=Lewis+G&amp;rft_id=http%3A%2F%2Fwww.bris.ac.uk%2Fpsychiatry%2Fstaff%2Fzammit%2Fdocuments%2Fpaper.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Degenhardt L, Hall W, Lynskey M (2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060819220505/http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_18/$file/TR.121.PDF\">\"Comorbidity between cannabis use and psychosis: Modelling some possible relationships\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Technical Report No. 121. Sydney: National Drug and Alcohol Research Centre. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_18/$file/TR.121.PDF\">the original</a> <span style=\"font-size:85%;\">(<a href=\"/wiki/PDF\" title=\"PDF\">PDF</a>)</span> on 19 August 2006<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 August</span> 2006</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Comorbidity+between+cannabis+use+and+psychosis%3A+Modelling+some+possible+relationships.&amp;rft.date=2001&amp;rft.aulast=Degenhardt&amp;rft.aufirst=L&amp;rft.au=Hall%2C+W&amp;rft.au=Lynskey%2C+M&amp;rft_id=http%3A%2F%2Fndarc.med.unsw.edu.au%2FNDARCWeb.nsf%2Fresources%2FTR_18%2F%24file%2FTR.121.PDF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Martin Frisher; Ilana Crome; Orsolina Martino; Peter Croft. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ukcia.org/research/keele_study/Assessing-the-impact-of-cannabis-use-on-trend-in-diagnosed-schizophrenia.pdf\">\"Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Schizophrenia Research</i>. <b>113</b> (2\u20133): 123\u2013128. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.schres.2009.05.031\">10.1016/j.schres.2009.05.031</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19560900\">19560900</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Research&amp;rft.atitle=Assessing+the+impact+of+cannabis+use+on+trends+in+diagnosed+schizophrenia+in+the+United+Kingdom+from+1996+to+2005&amp;rft.volume=113&amp;rft.issue=2%E2%80%933&amp;rft.pages=123-128&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1016%2Fj.schres.2009.05.031&amp;rft_id=info%3Apmid%2F19560900&amp;rft.au=Martin+Frisher&amp;rft.au=Ilana+Crome&amp;rft.au=Orsolina+Martino&amp;rft.au=Peter+Croft.&amp;rft_id=http%3A%2F%2Fwww.ukcia.org%2Fresearch%2Fkeele_study%2FAssessing-the-impact-of-cannabis-use-on-trend-in-diagnosed-schizophrenia.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20100922115831/http://www.nhsconfed.org/Publications/Documents/MHN_factsheet_August_2009_FINAL_2.pdf\">\"Archived copy\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nhsconfed.org/Publications/Documents/MHN_factsheet_August_2009_FINAL_2.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 22 September 2010<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-07-05</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.nhsconfed.org%2FPublications%2FDocuments%2FMHN_factsheet_August_2009_FINAL_2.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> Key facts and trends in mental health, National Health Service, 2009</span>\n</li>\n<li id=\"cite_note-van_Emmerik-van_Oortmerssen-2012-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-van_Emmerik-van_Oortmerssen-2012_28-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">van Emmerik-van Oortmerssen, K.; van de Glind, G.; van den Brink, W.; Smit, F.; Crunelle, CL.; Swets, M.; Schoevers, RA. (Apr 2012). \"Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis\". <i>Drug Alcohol Depend</i>. <b>122</b> (1\u20132): 11\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.drugalcdep.2011.12.007\">10.1016/j.drugalcdep.2011.12.007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22209385\">22209385</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Alcohol+Depend&amp;rft.atitle=Prevalence+of+attention-deficit+hyperactivity+disorder+in+substance+use+disorder+patients%3A+a+meta-analysis+and+meta-regression+analysis.&amp;rft.volume=122&amp;rft.issue=1%E2%80%932&amp;rft.pages=11-9&amp;rft.date=2012-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.drugalcdep.2011.12.007&amp;rft_id=info%3Apmid%2F22209385&amp;rft.aulast=van+Emmerik-van+Oortmerssen&amp;rft.aufirst=K.&amp;rft.au=van+de+Glind%2C+G.&amp;rft.au=van+den+Brink%2C+W.&amp;rft.au=Smit%2C+F.&amp;rft.au=Crunelle%2C+CL.&amp;rft.au=Swets%2C+M.&amp;rft.au=Schoevers%2C+RA.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Frodl-2010-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Frodl-2010_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Frodl-2010_29-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Frodl, T. (Sep 2010). \"Comorbidity of ADHD and Substance Use Disorder (SUD): a neuroimaging perspective\". <i>J Atten Disord</i>. <b>14</b> (2): 109\u201320. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/1087054710365054\">10.1177/1087054710365054</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20495160\">20495160</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Atten+Disord&amp;rft.atitle=Comorbidity+of+ADHD+and+Substance+Use+Disorder+%28SUD%29%3A+a+neuroimaging+perspective.&amp;rft.volume=14&amp;rft.issue=2&amp;rft.pages=109-20&amp;rft.date=2010-09&amp;rft_id=info%3Adoi%2F10.1177%2F1087054710365054&amp;rft_id=info%3Apmid%2F20495160&amp;rft.aulast=Frodl&amp;rft.aufirst=T.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Upadhyaya-2007-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Upadhyaya-2007_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Upadhyaya-2007_30-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Upadhyaya-2007_30-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Upadhyaya, HP. (2007). \"Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder\". <i>J Clin Psychiatry</i>. 68 Suppl 11: 23\u201330. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18307378\">18307378</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.atitle=Managing+attention-deficit%2Fhyperactivity+disorder+in+the+presence+of+substance+use+disorder.&amp;rft.volume=68+Suppl+11&amp;rft.pages=23-30&amp;rft.date=2007&amp;rft_id=info%3Apmid%2F18307378&amp;rft.aulast=Upadhyaya&amp;rft.aufirst=HP.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ramos-2013-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ramos-2013_31-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ramos, M.; Boada, L.; Moreno, C.; Llorente, C.; Romo, J.; Parellada, M. (Aug 2013). \"Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome\". <i>Drug Alcohol Depend</i>. <b>133</b> (2): 535\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.drugalcdep.2013.07.022\">10.1016/j.drugalcdep.2013.07.022</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23962420\">23962420</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Alcohol+Depend&amp;rft.atitle=Attitude+and+risk+of+substance+use+in+adolescents+diagnosed+with+Asperger+syndrome.&amp;rft.volume=133&amp;rft.issue=2&amp;rft.pages=535-40&amp;rft.date=2013-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.drugalcdep.2013.07.022&amp;rft_id=info%3Apmid%2F23962420&amp;rft.aulast=Ramos&amp;rft.aufirst=M.&amp;rft.au=Boada%2C+L.&amp;rft.au=Moreno%2C+C.&amp;rft.au=Llorente%2C+C.&amp;rft.au=Romo%2C+J.&amp;rft.au=Parellada%2C+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid18412750-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18412750_32-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Uekermann J, Daum I (May 2008). \"Social cognition in alcoholism: a link to prefrontal cortex dysfunction?\". <i>Addiction</i>. <b>103</b> (5): 726\u201335. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1360-0443.2008.02157.x\">10.1111/j.1360-0443.2008.02157.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18412750\">18412750</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Addiction&amp;rft.atitle=Social+cognition+in+alcoholism%3A+a+link+to+prefrontal+cortex+dysfunction%3F&amp;rft.volume=103&amp;rft.issue=5&amp;rft.pages=726-35&amp;rft.date=2008-05&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1360-0443.2008.02157.x&amp;rft_id=info%3Apmid%2F18412750&amp;rft.aulast=Uekermann&amp;rft.aufirst=J&amp;rft.au=Daum%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sellman D (2009). \"The 10 most important things known about addiction\". <i>Addiction</i>. <b>105</b>: 6\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1360-0443.2009.02673.x\">10.1111/j.1360-0443.2009.02673.x</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Addiction&amp;rft.atitle=The+10+most+important+things+known+about+addiction&amp;rft.volume=105&amp;rft.pages=6-13&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1360-0443.2009.02673.x&amp;rft.au=Sellman+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-robertwhitaker.org-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-robertwhitaker.org_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-robertwhitaker.org_34-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://robertwhitaker.org/robertwhitaker.org/Anatomy%20of%20an%20Epidemic.html\">http://robertwhitaker.org/robertwhitaker.org/Anatomy%20of%20an%20Epidemic.html</a></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://knowledgeisnecessity.blogspot.com/2010/11/supersensitivity-psychosis-evidence.html\">http://knowledgeisnecessity.blogspot.com/2010/11/supersensitivity-psychosis-evidence.html</a></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.ahrp.org/risks/biblio0100.php\">http://www.ahrp.org/risks/biblio0100.php</a></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Steiner W. \"Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder\". <i><a href=\"/wiki/Acta_Psychiatrica_Scandinavica\" title=\"Acta Psychiatrica Scandinavica\">Acta Psychiatrica Scandinavica</a></i>. <b>81</b>: 437\u2013440. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1600-0447.1990.tb05477.x\">10.1111/j.1600-0447.1990.tb05477.x</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica&amp;rft.atitle=Neuroleptic-induced+supersensitivity+psychosis+in+patients+with+bipolar+affective+disorder&amp;rft.volume=81&amp;rft.pages=437-440&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.1990.tb05477.x&amp;rft.au=Steiner+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://breggin.com/index.php?option=com_docman&amp;task=doc_download&amp;gid=232&amp;Itemid=37\">http://breggin.com/index.php?option=com_docman&amp;task=doc_download&amp;gid=232&amp;Itemid=37</a></span>\n</li>\n<li id=\"cite_note-Khantzian-39\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Khantzian_39-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Khantzian_39-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Khantzian EJ (1997). \"The self-medication hypothesis of substance use disorders: a reconsideration and recent applications\". <i>Harv Rev Psychiatry</i>. <b>4</b> (5): 231\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/10673229709030550\">10.3109/10673229709030550</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9385000\">9385000</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Harv+Rev+Psychiatry&amp;rft.atitle=The+self-medication+hypothesis+of+substance+use+disorders%3A+a+reconsideration+and+recent+applications&amp;rft.volume=4&amp;rft.issue=5&amp;rft.pages=231-44&amp;rft.date=1997&amp;rft_id=info%3Adoi%2F10.3109%2F10673229709030550&amp;rft_id=info%3Apmid%2F9385000&amp;rft.au=Khantzian+EJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid12377405-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12377405_40-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yang YK, Nelson L, Kamaraju L, Wilson W, McEvoy JP (October 2002). \"Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia\". <i>Neuropsychopharmacology</i>. <b>27</b> (4): 684\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0893-133X%2802%2900325-1\">10.1016/S0893-133X(02)00325-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12377405\">12377405</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.atitle=Nicotine+decreases+bradykinesia-rigidity+in+haloperidol-treated+patients+with+schizophrenia&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=684-6&amp;rft.date=2002-10&amp;rft_id=info%3Adoi%2F10.1016%2FS0893-133X%2802%2900325-1&amp;rft_id=info%3Apmid%2F12377405&amp;rft.aulast=Yang&amp;rft.aufirst=YK&amp;rft.au=Nelson%2C+L&amp;rft.au=Kamaraju%2C+L&amp;rft.au=Wilson%2C+W&amp;rft.au=McEvoy%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid15008806-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15008806_41-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Silvestri S, Negrete JC, Seeman MV, Shammi CM, Seeman P (April 2004). <a rel=\"nofollow\" class=\"external text\" href=\"http://www3.interscience.wiley.com/resolve/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=0001-690X&amp;date=2004&amp;volume=109&amp;issue=4&amp;spage=313\">\"Does nicotine affect D2 receptor upregulation? A case-control study\"</a>. <i>Acta Psychiatr Scand</i>. <b>109</b> (4): 313\u20137; discussion 317\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1600-0447.2004.00293.x\">10.1111/j.1600-0447.2004.00293.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15008806\">15008806</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Psychiatr+Scand&amp;rft.atitle=Does+nicotine+affect+D2+receptor+upregulation%3F+A+case-control+study&amp;rft.volume=109&amp;rft.issue=4&amp;rft.pages=313-7%3B+discussion+317-8&amp;rft.date=2004-04&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.2004.00293.x&amp;rft_id=info%3Apmid%2F15008806&amp;rft.aulast=Silvestri&amp;rft.aufirst=S&amp;rft.au=Negrete%2C+JC&amp;rft.au=Seeman%2C+MV&amp;rft.au=Shammi%2C+CM&amp;rft.au=Seeman%2C+P&amp;rft_id=http%3A%2F%2Fwww3.interscience.wiley.com%2Fresolve%2Fopenurl%3Fgenre%3Darticle%26sid%3Dnlm%3Apubmed%26issn%3D0001-690X%26date%3D2004%26volume%3D109%26issue%3D4%26spage%3D313&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pristach CA; Smith CM (1996). \"Self-reported effects of alcohol use on symptoms of schizophrenia\". <i>Psychiatr Serv</i>. <b>47</b> (4): 421\u20133. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8689377\">8689377</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatr+Serv&amp;rft.atitle=Self-reported+effects+of+alcohol+use+on+symptoms+of+schizophrenia&amp;rft.volume=47&amp;rft.issue=4&amp;rft.pages=421-3&amp;rft.date=1996&amp;rft_id=info%3Apmid%2F8689377&amp;rft.au=Pristach+CA&amp;rft.au=Smith+CM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\">Anthony, J.C. &amp; Helzer, J.E. 1991, \"Syndromes of drug abuse and dependence\", in Psychiatric Disorders in America: The Epidemiologic Catchment Area Study, L.N. Robins &amp; D.A. Regier, eds., Free Press, New York, pp. 116\u2013154.</span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Berman, S; Noble, EP (1993). \"Childhood antecedents of substance misuse\". <i><a href=\"/wiki/Current_Opinion_in_Psychiatry\" class=\"mw-redirect\" title=\"Current Opinion in Psychiatry\">Current Opinion in Psychiatry</a></i>. <b>6</b> (3): 382\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00001504-199306000-00012\">10.1097/00001504-199306000-00012</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Psychiatry&amp;rft.atitle=Childhood+antecedents+of+substance+misuse&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=382-7&amp;rft.date=1993&amp;rft_id=info%3Adoi%2F10.1097%2F00001504-199306000-00012&amp;rft.au=Berman%2C+S&amp;rft.au=Noble%2C+EP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\">Banerjee, S., Clancy, C., &amp; Crome, I. 2002, \"Co-existing Problems of Mental Disorder and Substance Misuse (dual diagnosis). An Information Manual. Found at <a rel=\"nofollow\" class=\"external free\" href=\"http://www.rcpsych.ac.uk\">http://www.rcpsych.ac.uk</a>\", Royal College of Psychiatrists' Research Unit.</span>\n</li>\n<li id=\"cite_note-mueser_AB-46\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-mueser_AB_46-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-mueser_AB_46-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mueser KT; Drake RE; Wallach MA (1998). \"Dual diagnosis: a review of etiological theories\". <i><a href=\"/wiki/Addictive_Behaviors\" title=\"Addictive Behaviors\">Addictive Behaviors</a></i>. <b>23</b> (6): 717\u201334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0306-4603%2898%2900073-2\">10.1016/S0306-4603(98)00073-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9801712\">9801712</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Addictive+Behaviors&amp;rft.atitle=Dual+diagnosis%3A+a+review+of+etiological+theories&amp;rft.volume=23&amp;rft.issue=6&amp;rft.pages=717-34&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1016%2FS0306-4603%2898%2900073-2&amp;rft_id=info%3Apmid%2F9801712&amp;rft.au=Mueser+KT&amp;rft.au=Drake+RE&amp;rft.au=Wallach+MA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\">Szerman N, Martinez-Raga J, Peris L. et al. Rethinking Dual Disorders. Addictive Disorders &amp; Their Treatment. Epub ahead August 2012</span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zimmerman M, Chelminski I, Young D;  et al. (2011). \"Does DSM-IV capture the dimensional nature of personality disorders?\". <i>J Clin Psychiatry</i>. <b>72</b>: 1333\u20131339. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4088/jcp.11m06974\">10.4088/jcp.11m06974</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.atitle=Does+DSM-IV+capture+the+dimensional+nature+of+personality+disorders%3F&amp;rft.volume=72&amp;rft.pages=1333-1339&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.4088%2Fjcp.11m06974&amp;rft.au=Zimmerman+M%2C+Chelminski+I%2C+Young+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Explicit use of et al. (<a href=\"/wiki/Category:CS1_maint:_Explicit_use_of_et_al.\" title=\"Category:CS1 maint: Explicit use of et al.\">link</a>) CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-Drake_1998-49\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Drake_1998_49-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Drake_1998_49-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Drake, Robert E.; Mercer-McFadden, Carolyn; Mueser, Kim T.; McHugo, Gregory J.; Bond, Gary R. (1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.psycontent.com/content/n39l485nw88726p7/\">\"Review of Integrated Mental Health and Substance Abuse Treatment for Patients With Dual Disorders\"</a>. <i>Schizophrenia Bulletin</i>. <b>24</b> (4): 589\u2013608. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/oxfordjournals.schbul.a033351\">10.1093/oxfordjournals.schbul.a033351</a><span class=\"reference-accessdate\">. Retrieved July 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Bulletin&amp;rft.atitle=Review+of+Integrated+Mental+Health+and+Substance+Abuse+Treatment+for+Patients+With+Dual+Disorders&amp;rft.volume=24&amp;rft.issue=4&amp;rft.pages=589-608&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1093%2Foxfordjournals.schbul.a033351&amp;rft.aulast=Drake&amp;rft.aufirst=Robert+E.&amp;rft.au=Mercer-McFadden%2C+Carolyn&amp;rft.au=Mueser%2C+Kim+T.&amp;rft.au=McHugo%2C+Gregory+J.&amp;rft.au=Bond%2C+Gary+R.&amp;rft_id=http%3A%2F%2Fwww.psycontent.com%2Fcontent%2Fn39l485nw88726p7%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-Drake_2000-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Drake_2000_50-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Drake, Robert E.; Mueser, Kim T. (2000). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.psycontent.com/content/9w2u042h31831812/\">\"Psychosocial Approaches to Dual Diagnosis\"</a>. <i>Schizophrenia Bulletin</i>. <b>26</b> (1): 105\u2013118. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/oxfordjournals.schbul.a033429\">10.1093/oxfordjournals.schbul.a033429</a><span class=\"reference-accessdate\">. Retrieved July 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Bulletin&amp;rft.atitle=Psychosocial+Approaches+to+Dual+Diagnosis&amp;rft.volume=26&amp;rft.issue=1&amp;rft.pages=105-118&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1093%2Foxfordjournals.schbul.a033429&amp;rft.aulast=Drake&amp;rft.aufirst=Robert+E.&amp;rft.au=Mueser%2C+Kim+T.&amp;rft_id=http%3A%2F%2Fwww.psycontent.com%2Fcontent%2F9w2u042h31831812%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-51\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Gorman, Christine (3 August 1987). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.time.com/time/magazine/article/0,9171,965144,00.html\">\"Bad Trips for the Doubly Troubled\"</a>. <i>TIME Magazine</i><span class=\"reference-accessdate\">. Retrieved July 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=TIME+Magazine&amp;rft.atitle=Bad+Trips+for+the+Doubly+Troubled&amp;rft.date=1987-08-03&amp;rft.aulast=Gorman&amp;rft.aufirst=Christine&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fmagazine%2Farticle%2F0%2C9171%2C965144%2C00.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-Drake_2001-52\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Drake_2001_52-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Drake_2001_52-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Drake_2001_52-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Drake, Robert E.; Essock, Susan M.; Shaner, Andrew; Carey, Kate B.; Minkoff, Kenneth; Kola, Lenore; Lynde, David; Osher, Fred C.; Clark, Robin E.; Rickards, Lawrence (1 April 2001). <a rel=\"nofollow\" class=\"external text\" href=\"http://ps.psychiatryonline.org/article.aspx?articleid=85734&amp;link_type=googlescholarrelated\">\"Implementing Dual Diagnosis Services for Clients With Severe Mental Illness\"</a>. <i>Psychiatric Services</i>. <b>54</b> (1): 469\u2013476. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1176/appi.ps.52.4.469\">10.1176/appi.ps.52.4.469</a><span class=\"reference-accessdate\">. Retrieved July 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatric+Services&amp;rft.atitle=Implementing+Dual+Diagnosis+Services+for+Clients+With+Severe+Mental+Illness&amp;rft.volume=54&amp;rft.issue=1&amp;rft.pages=469-476&amp;rft.date=2001-04-01&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ps.52.4.469&amp;rft.aulast=Drake&amp;rft.aufirst=Robert+E.&amp;rft.au=Essock%2C+Susan+M.&amp;rft.au=Shaner%2C+Andrew&amp;rft.au=Carey%2C+Kate+B.&amp;rft.au=Minkoff%2C+Kenneth&amp;rft.au=Kola%2C+Lenore&amp;rft.au=Lynde%2C+David&amp;rft.au=Osher%2C+Fred+C.&amp;rft.au=Clark%2C+Robin+E.&amp;rft.au=Rickards%2C+Lawrence&amp;rft_id=http%3A%2F%2Fps.psychiatryonline.org%2Farticle.aspx%3Farticleid%3D85734%26link_type%3Dgooglescholarrelated&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sciacca, K._1991. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/17222783/An-Integrated-Treatment-Approach-for-Severely-Mentally-Ill-Individuals-With-Substance-Disorders-Kathleen-Sciacca\">\"An Integrated Treatment Approach for Severely Mentally Ill Individuals with Substance Disorders\"</a>. <i>New Directions For Mental Health Services, No. 50, Summer 1991, Chapter 6: Jossey-Bass, Publishers</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+Directions+For+Mental+Health+Services%2C+No.+50%2C+Summer+1991%2C+Chapter+6%3A+Jossey-Bass%2C+Publishers&amp;rft.atitle=An+Integrated+Treatment+Approach+for+Severely+Mentally+Ill+Individuals+with+Substance+Disorders&amp;rft.aulast=Sciacca&amp;rft.aufirst=K._1991&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F17222783%2FAn-Integrated-Treatment-Approach-for-Severely-Mentally-Ill-Individuals-With-Substance-Disorders-Kathleen-Sciacca&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-54\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sciacca, Kathleen (July 1996). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/16684317/On-Cooccurring-Addictive-Mental-Disorders-a-Brief-History-Kathleen-Sciacca\">\"Invited response \"On Co-Occurring Addictive and Mental Disorders; A Brief History of the Origins of Dual Diagnosis Treatment and Program Development<span style=\"padding-right:0.2em;\">\"</span>\"</a>. <i><a href=\"/wiki/American_Journal_of_Orthopsychiatry\" title=\"American Journal of Orthopsychiatry\">American Journal of Orthopsychiatry</a></i>. <b>66</b> (3)<span class=\"reference-accessdate\">. Retrieved July 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Orthopsychiatry&amp;rft.atitle=Invited+response+%22On+Co-Occurring+Addictive+and+Mental+Disorders%3B+A+Brief+History+of+the+Origins+of+Dual+Diagnosis+Treatment+and+Program+Development%22&amp;rft.volume=66&amp;rft.issue=3&amp;rft.date=1996-07&amp;rft.aulast=Sciacca&amp;rft.aufirst=Kathleen&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F16684317%2FOn-Cooccurring-Addictive-Mental-Disorders-a-Brief-History-Kathleen-Sciacca&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-55\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sciacca, Kathleen; Thompson, Christina M. (Summer 1996). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/17223077/Program-Development-and-Integrated-Treatment-Across-Systems-for-Dual-Diagnosis-Kathleen-Sciacca\">\"Program Development and Integrated Treatment Across Systems for Dual Diagnosis: Mental Illness, Drug Addiction And Alcoholism, MIDAA\"</a>. <i>Journal of Mental Health Administration</i>. <b>23</b> (3): 288\u2013297. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/bf02522303\">10.1007/bf02522303</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Mental+Health+Administration&amp;rft.atitle=Program+Development+and+Integrated+Treatment+Across+Systems+for+Dual+Diagnosis%3A+Mental+Illness%2C+Drug+Addiction+And+Alcoholism%2C+MIDAA&amp;rft.ssn=summer&amp;rft.volume=23&amp;rft.issue=3&amp;rft.pages=288-297&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1007%2Fbf02522303&amp;rft.aulast=Sciacca&amp;rft.aufirst=Kathleen&amp;rft.au=Thompson%2C+Christina+M.&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F17223077%2FProgram-Development-and-Integrated-Treatment-Across-Systems-for-Dual-Diagnosis-Kathleen-Sciacca&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Dual_diagnosis&amp;action=edit&amp;section=18\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>Alegr\u00eda BS., Analucia A., Blanco C. \"Differences among major depressive disorder with and without Co-occurring Substance Use Disorders and Substance-Induced Depressive disorder: results from the NESARC\" <i>J Clin Psychiatry</i> 2012; 73; 865-873.</li>\n<li><cite class=\"citation journal\">Sciacca, Kathleen_2009. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/21801032/BestPracticesForDualDiagnosisTreatment-ProgramDevelopment-Co-occurring-Mental-Illness-Substance-Disorders-Kathleen-Sciacca-2009\">\"Best Practices for Dual Diagnosis Treatment and Program Development: Co-occurring Mental Illness and Substance Disorders in Various Combinations\"</a>. <i>The Praeger International Collection on Addictions, Editor, Angela Brown-Miller, Vol. 3, Chapter 9, Pgs. 161-188, Praeger, Westport, CT. London</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Praeger+International+Collection+on+Addictions%2C+Editor%2C+Angela+Brown-Miller%2C+Vol.+3%2C+Chapter+9%2C+Pgs.+161-188%2C+Praeger%2C+Westport%2C+CT.+London.&amp;rft.atitle=Best+Practices+for+Dual+Diagnosis+Treatment+and+Program+Development%3A+Co-occurring+Mental+Illness+and+Substance+Disorders+in+Various+Combinations&amp;rft.aulast=Sciacca&amp;rft.aufirst=Kathleen_2009&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F21801032%2FBestPracticesForDualDiagnosisTreatment-ProgramDevelopment-Co-occurring-Mental-Illness-Substance-Disorders-Kathleen-Sciacca-2009&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Sciacca, K. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/52145406/Integrated-group-treatment-for-people-experiencing-mental-health\u2013substance-use-problems-Kathleen-Sciacca\">\"Integrated Group Treatment for People Experiencing Mental Health - Substance Use Problems\"</a>. <i>Intervention in Mental Health - Substance Use, Editor, David B. Cooper, Chapter 9, pgs. 114-127, Radcliffe Pub. London, New York</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Intervention+in+Mental+Health+-+Substance+Use%2C+Editor%2C+David+B.+Cooper%2C+Chapter+9%2C+pgs.+114-127%2C+Radcliffe+Pub.+London%2C+New+York&amp;rft.atitle=Integrated+Group+Treatment+for+People+Experiencing+Mental+Health+-+Substance+Use+Problems&amp;rft.date=2011&amp;rft.au=Sciacca%2C+K.&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F52145406%2FIntegrated-group-treatment-for-people-experiencing-mental-health%E2%80%93substance-use-problems-Kathleen-Sciacca&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Sciacca,, K., Hatfield, A.B._1995. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/17222954/The-Family-and-the-Dually-Diagnosed-Patient-Kathleen-Sciacca\">\"The Family and the Dually Diagnosed Patient\"</a>. <i>Double Jeopardy, Eds. Lehman, A.F., and Dixon, L.B., Harwood Academic Publishers, 1995, Chapter 12, pp.193-209</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Double+Jeopardy%2C+Eds.+Lehman%2C+A.F.%2C+and+Dixon%2C+L.B.%2C+Harwood+Academic+Publishers%2C+1995%2C+Chapter+12%2C+pp.193-209.&amp;rft.atitle=The+Family+and+the+Dually+Diagnosed+Patient&amp;rft.aulast=Sciacca%2C&amp;rft.aufirst=K.%2C+Hatfield%2C+A.B._1995&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F17222954%2FThe-Family-and-the-Dually-Diagnosed-Patient-Kathleen-Sciacca&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Giglioti, M. A._1986. <a rel=\"nofollow\" class=\"external text\" href=\"http://users.erols.com/ksciacca/giglioti.htm\">\"Program Initiatives for Dually-Diagnosed at Harlem Valley Psychiatric Center. Dual Diagnosis -Co-occurring Disorders\"</a>. <i>New York State Commission on Quality of Care Publication, Issue 28, October 1986</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+State+Commission+on+Quality+of+Care+Publication%2C+Issue+28%2C+October+1986.&amp;rft.atitle=Program+Initiatives+for+Dually-Diagnosed+at+Harlem+Valley+Psychiatric+Center.+Dual+Diagnosis+-Co-occurring+Disorders&amp;rft.aulast=Giglioti&amp;rft.aufirst=M.+A._1986&amp;rft_id=http%3A%2F%2Fusers.erols.com%2Fksciacca%2Fgiglioti.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Samet S, Nunes E, Hassin D;  et al. (2006). \"Diagnosis of comorbid psychiatric disorders in substance users assesses with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV\". <i>Am J Psychiatry</i>. <b>163</b>: 689\u2013696. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1176/appi.ajp.163.4.689\">10.1176/appi.ajp.163.4.689</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.atitle=Diagnosis+of+comorbid+psychiatric+disorders+in+substance+users+assesses+with+the+Psychiatric+Research+Interview+for+Substance+and+Mental+Disorders+for+DSM-IV&amp;rft.volume=163&amp;rft.pages=689-696&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ajp.163.4.689&amp;rft.au=Samet+S%2C+Nunes+E%2C+Hassin+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Explicit use of et al. (<a href=\"/wiki/Category:CS1_maint:_Explicit_use_of_et_al.\" title=\"Category:CS1 maint: Explicit use of et al.\">link</a>) CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></li>\n<li><cite class=\"citation journal\">Sciacca, K._1997. <a rel=\"nofollow\" class=\"external text\" href=\"http://motivationalinterviewingtraining.com/uploads/scan_1_HelpfullPeopleInTouchChapt..pdf\">\"Peer Support for People Challenged by Dual Diagnosis: \"Helpful People In Touch\" (Consumer Led Self-Help)\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Consumers as Providers in Psychosocial Rehabilitation, Eds. Mowbray, C.T., Moxley, D.P., Jasper, C.A., Howell, L.L., IAPSRS publisher, 1997. Chapter 6, pp. 82</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Consumers+as+Providers+in+Psychosocial+Rehabilitation%2C+Eds.+Mowbray%2C+C.T.%2C+Moxley%2C+D.P.%2C+Jasper%2C+C.A.%2C+Howell%2C+L.L.%2C+IAPSRS+publisher%2C+1997.+Chapter+6%2C+pp.+82.&amp;rft.atitle=Peer+Support+for+People+Challenged+by+Dual+Diagnosis%3A+%22Helpful+People+In+Touch%22+%28Consumer+Led+Self-Help%29&amp;rft.aulast=Sciacca&amp;rft.aufirst=K._1997&amp;rft_id=http%3A%2F%2Fmotivationalinterviewingtraining.com%2Fuploads%2Fscan_1_HelpfullPeopleInTouchChapt..pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADual+diagnosis\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li>Todd FC, Sellman JD, Adamson SJ et al. Co-existing psychiatric disorders in a New Zealand outpatients alcohol and other drug clinical population. Aust NZ J Psychiatry 2006;40:164-170.</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2164\nCached time: 20180913014143\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.708 seconds\nReal time usage: 0.760 seconds\nPreprocessor visited node count: 2903/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 111967/2097152 bytes\nTemplate argument size: 2158/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 3/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 67250/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.406/10.000 seconds\nLua memory usage: 5 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  656.537      1 -total\n 67.39%  442.464      1 Template:Reflist\n 42.62%  279.799     39 Template:Cite_journal\n 13.31%   87.364      8 Template:Cite_web\n  6.50%   42.692      3 Template:Citation_needed\n  5.93%   38.924      1 Template:Clarify\n  5.76%   37.835      3 Template:Fix\n  5.49%   36.021      1 Template:About\n  5.48%   35.996      1 Template:Fix-span\n  4.59%   30.111      8 Template:Category_handler\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:12391913-0!canonical and timestamp 20180913014142 and revision id 859287289\n -->\n</div>"},"langlinks":[{"lang":"fa","url":"https://fa.wikipedia.org/wiki/%D8%AA%D8%B4%D8%AE%DB%8C%D8%B5_%D8%AF%D9%88%DA%AF%D8%A7%D9%86%D9%87","langname":"Persian","autonym":"\u0641\u0627\u0631\u0633\u06cc","*":"\u062a\u0634\u062e\u06cc\u0635 \u062f\u0648\u06af\u0627\u0646\u0647"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%AA%D7%97%D7%9C%D7%95%D7%90%D7%94_%D7%9B%D7%A4%D7%95%D7%9C%D7%94","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05ea\u05d7\u05dc\u05d5\u05d0\u05d4 \u05db\u05e4\u05d5\u05dc\u05d4"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Dobbeltdiagnose_(rus_og_psykisk_lidelse)","langname":"Norwegian","autonym":"norsk","*":"Dobbeltdiagnose (rus og psykisk lidelse)"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Podw%C3%B3jne_rozpoznanie","langname":"Polish","autonym":"polski","*":"Podw\u00f3jne rozpoznanie"},{"lang":"sr","url":"https://sr.wikipedia.org/wiki/%D0%94%D1%83%D0%B0%D0%BB%D0%BD%D0%B0_%D0%B4%D0%B8%D1%98%D0%B0%D0%B3%D0%BD%D0%BE%D0%B7%D0%B0","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"\u0414\u0443\u0430\u043b\u043d\u0430 \u0434\u0438\u0458\u0430\u0433\u043d\u043e\u0437\u0430"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Dubbeldiagnos","langname":"Swedish","autonym":"svenska","*":"Dubbeldiagnos"}],"categories":[{"sortkey":"Dual Diagnosis","hidden":"","*":"CS1_maint:_Multiple_names:_authors_list"},{"sortkey":"Dual Diagnosis","hidden":"","*":"CS1_maint:_Explicit_use_of_et_al."},{"sortkey":"","hidden":"","*":"CS1_errors:_dates"},{"sortkey":"Dual Diagnosis","hidden":"","*":"Use_dmy_dates_from_April_2012"},{"sortkey":"Dual Diagnosis","hidden":"","*":"Wikipedia_articles_needing_clarification_from_April_2013"},{"sortkey":"Dual Diagnosis","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"Dual Diagnosis","hidden":"","*":"Articles_with_unsourced_statements_from_November_2012"},{"sortkey":"Dual Diagnosis","*":"Addiction_psychiatry"},{"sortkey":"Dual Diagnosis","*":"Substance-related_disorders"},{"sortkey":"Dual Diagnosis","*":"Drug_rehabilitation"},{"sortkey":"Dual Diagnosis","*":"Substance_dependence"},{"sortkey":"Dual Diagnosis","*":"Alcohol_abuse"},{"sortkey":"Dual Diagnosis","*":"2_(number)"}],"links":[{"ns":14,"exists":"","*":"Category:Use dmy dates from April 2012"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing clarification from April 2013"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from November 2012"},{"ns":14,"exists":"","*":"Category:CS1 maint: Explicit use of et al."},{"ns":14,"exists":"","*":"Category:CS1 maint: Multiple names: authors list"},{"ns":0,"exists":"","*":"Abuse"},{"ns":0,"exists":"","*":"Acta Psychiatrica Scandinavica"},{"ns":0,"exists":"","*":"Addictive Behaviors"},{"ns":0,"exists":"","*":"Alcohol abuse"},{"ns":0,"exists":"","*":"Alcoholic beverage"},{"ns":0,"exists":"","*":"American Journal of Orthopsychiatry"},{"ns":0,"exists":"","*":"Amphetamine"},{"ns":0,"exists":"","*":"Antipsychotic"},{"ns":0,"exists":"","*":"Anxiety"},{"ns":0,"exists":"","*":"Archives of General Psychiatry"},{"ns":0,"exists":"","*":"Attention-deficit hyperactivity disorder"},{"ns":0,"exists":"","*":"Baclofen"},{"ns":0,"exists":"","*":"Benzodiazepines"},{"ns":0,"exists":"","*":"Boredom"},{"ns":0,"exists":"","*":"Bradykinesia"},{"ns":0,"exists":"","*":"British Journal of Psychiatry"},{"ns":0,"exists":"","*":"Bupropion"},{"ns":0,"exists":"","*":"Cannabis"},{"ns":0,"exists":"","*":"Cannabis abuse"},{"ns":0,"exists":"","*":"Clozapine"},{"ns":0,"exists":"","*":"Comorbid"},{"ns":0,"exists":"","*":"Comorbidity"},{"ns":0,"exists":"","*":"Croydon"},{"ns":0,"exists":"","*":"Current Opinion in Psychiatry"},{"ns":0,"exists":"","*":"DSM-IV"},{"ns":0,"exists":"","*":"Diagnostic"},{"ns":0,"exists":"","*":"Diagnostic and Statistical Manual of Mental Disorders"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Disease"},{"ns":0,"exists":"","*":"Drug withdrawal"},{"ns":0,"exists":"","*":"Dyskinesia"},{"ns":0,"exists":"","*":"Dysphoria"},{"ns":0,"exists":"","*":"Dysthymia"},{"ns":0,"exists":"","*":"Environment (biophysical)"},{"ns":0,"exists":"","*":"Exposure to toxins"},{"ns":0,"exists":"","*":"Generalized anxiety disorder"},{"ns":0,"exists":"","*":"HIV"},{"ns":0,"exists":"","*":"Hallucinogens"},{"ns":0,"exists":"","*":"Hepatitis C"},{"ns":0,"exists":"","*":"Heterogeneous"},{"ns":0,"exists":"","*":"Homelessness"},{"ns":0,"exists":"","*":"Insomnia"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Journal of the American Medical Association"},{"ns":0,"exists":"","*":"Loneliness"},{"ns":0,"exists":"","*":"Major depression"},{"ns":0,"exists":"","*":"Mental illness"},{"ns":0,"exists":"","*":"Mood disorder"},{"ns":0,"exists":"","*":"Narcotics"},{"ns":0,"exists":"","*":"Neuronal"},{"ns":0,"exists":"","*":"Nicotine"},{"ns":0,"exists":"","*":"Opioid"},{"ns":0,"exists":"","*":"Opioid dependency"},{"ns":0,"exists":"","*":"PDF"},{"ns":0,"exists":"","*":"Panic disorder"},{"ns":0,"exists":"","*":"Post-acute-withdrawal syndrome"},{"ns":0,"exists":"","*":"Prefrontal cortex"},{"ns":0,"exists":"","*":"Prevalence"},{"ns":0,"exists":"","*":"Protracted withdrawal syndrome"},{"ns":0,"exists":"","*":"Psychiatric"},{"ns":0,"exists":"","*":"Psychoactive drug"},{"ns":0,"exists":"","*":"Psychological trauma"},{"ns":0,"exists":"","*":"Psychosis"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"SAMHSA"},{"ns":0,"exists":"","*":"Schizophrenia"},{"ns":0,"exists":"","*":"Schizophrenia Research"},{"ns":0,"exists":"","*":"Sedation"},{"ns":0,"exists":"","*":"Self-image"},{"ns":0,"exists":"","*":"Self-medication"},{"ns":0,"exists":"","*":"Serotonin-norepinephrine reuptake inhibitor"},{"ns":0,"exists":"","*":"Sobriety"},{"ns":0,"exists":"","*":"Social Psychiatry & Psychiatric Epidemiology"},{"ns":0,"exists":"","*":"Social isolation"},{"ns":0,"exists":"","*":"Social skills"},{"ns":0,"exists":"","*":"Stimulant"},{"ns":0,"exists":"","*":"Street drug"},{"ns":0,"exists":"","*":"Structured interview"},{"ns":0,"exists":"","*":"Substance abuse problem"},{"ns":0,"exists":"","*":"Synapses"},{"ns":0,"exists":"","*":"The Lancet"},{"ns":0,"exists":"","*":"Theory of mind"},{"ns":0,"exists":"","*":"Venlafaxine"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Please clarify"},{"ns":12,"exists":"","*":"Help:CS1 errors"}],"templates":[{"ns":10,"exists":"","*":"Template:About"},{"ns":10,"exists":"","*":"Template:Use dmy dates"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Clarify"},{"ns":10,"exists":"","*":"Template:Fix-span"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Replace"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:About"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Pagetype"},{"ns":828,"exists":"","*":"Module:Pagetype/config"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Namespace detect"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":[],"externallinks":["http://www.samhsa.gov/reports/congress2002/chap1ucod.htm","http://www.parl.gc.ca/Content/SEN/Committe/391/soci/rep/pdf/rep02may06part1-e.pdf","https://books.google.com/books?id=lvUzR0obihEC","http://www.samhsa.gov/data/NSDUH/2k11MH_FindingsandDetTables/2K11MHFR/NSDUHmhfr2011.htm","http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/pubs/adp-apd/bp_disorder-mp_concomitants/bp_concurrent_mental_health-eng.pdf","//doi.org/10.1001/archpsyc.1994.03950010008002","//www.ncbi.nlm.nih.gov/pubmed/8279933","//doi.org/10.1001/jama.264.19.2511","//www.ncbi.nlm.nih.gov/pubmed/2232018","//www.ncbi.nlm.nih.gov/pubmed/8375841","http://bjp.rcpsych.org/cgi/content/full/182/4/324","//doi.org/10.1192/bjp.182.4.324","//www.ncbi.nlm.nih.gov/pubmed/12668408","//doi.org/10.1007/s001270050242","//www.ncbi.nlm.nih.gov/pubmed/11016524","//doi.org/10.1192/bjp.183.4.304","//doi.org/10.2975/27.2004.360.374","https://www.scribd.com/doc/21801032/BestPracticesForDualDiagnosisTreatment-ProgramDevelopment-Co-occurring-Mental-Illness-Substance-Disorders-Kathleen-Sciacca-2009","https://web.archive.org/web/20141006081559/http://store.samhsa.gov/shin/content//PHD1132/PHD1132.pdf","http://store.samhsa.gov/shin/content//PHD1132/PHD1132.pdf","http://psychiatryonline.org/content.aspx?bookid=28&sectionid=1675010","http://www.ccsa.ca/ceca/pdf/Main-reportFINALa.pdf","http://www.psychiatrictimes.com/paranoia/article/10168/1390341","//doi.org/10.1016/S0920-9964(00)00065-7","//www.ncbi.nlm.nih.gov/pubmed/11278157","http://www.bris.ac.uk/psychiatry/staff/zammit/documents/paper.pdf","//doi.org/10.1016/S0140-6736(07)61162-3","//www.ncbi.nlm.nih.gov/pubmed/17662880","https://web.archive.org/web/20060819220505/http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_18/$file/TR.121.PDF","http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_18/$file/TR.121.PDF","http://www.ukcia.org/research/keele_study/Assessing-the-impact-of-cannabis-use-on-trend-in-diagnosed-schizophrenia.pdf","//doi.org/10.1016/j.schres.2009.05.031","//www.ncbi.nlm.nih.gov/pubmed/19560900","https://web.archive.org/web/20100922115831/http://www.nhsconfed.org/Publications/Documents/MHN_factsheet_August_2009_FINAL_2.pdf","http://www.nhsconfed.org/Publications/Documents/MHN_factsheet_August_2009_FINAL_2.pdf","//doi.org/10.1016/j.drugalcdep.2011.12.007","//www.ncbi.nlm.nih.gov/pubmed/22209385","//doi.org/10.1177/1087054710365054","//www.ncbi.nlm.nih.gov/pubmed/20495160","//www.ncbi.nlm.nih.gov/pubmed/18307378","//doi.org/10.1016/j.drugalcdep.2013.07.022","//www.ncbi.nlm.nih.gov/pubmed/23962420","//doi.org/10.1111/j.1360-0443.2008.02157.x","//www.ncbi.nlm.nih.gov/pubmed/18412750","//doi.org/10.1111/j.1360-0443.2009.02673.x","//doi.org/10.1111/j.1600-0447.1990.tb05477.x","//doi.org/10.3109/10673229709030550","//www.ncbi.nlm.nih.gov/pubmed/9385000","//doi.org/10.1016/S0893-133X(02)00325-1","//www.ncbi.nlm.nih.gov/pubmed/12377405","http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0001-690X&date=2004&volume=109&issue=4&spage=313","//doi.org/10.1111/j.1600-0447.2004.00293.x","//www.ncbi.nlm.nih.gov/pubmed/15008806","//www.ncbi.nlm.nih.gov/pubmed/8689377","//doi.org/10.1097/00001504-199306000-00012","//doi.org/10.1016/S0306-4603(98)00073-2","//www.ncbi.nlm.nih.gov/pubmed/9801712","//doi.org/10.4088/jcp.11m06974","http://www.psycontent.com/content/n39l485nw88726p7/","//doi.org/10.1093/oxfordjournals.schbul.a033351","http://www.psycontent.com/content/9w2u042h31831812/","//doi.org/10.1093/oxfordjournals.schbul.a033429","http://www.time.com/time/magazine/article/0,9171,965144,00.html","http://ps.psychiatryonline.org/article.aspx?articleid=85734&link_type=googlescholarrelated","//doi.org/10.1176/appi.ps.52.4.469","https://www.scribd.com/doc/17222783/An-Integrated-Treatment-Approach-for-Severely-Mentally-Ill-Individuals-With-Substance-Disorders-Kathleen-Sciacca","https://www.scribd.com/doc/16684317/On-Cooccurring-Addictive-Mental-Disorders-a-Brief-History-Kathleen-Sciacca","https://www.scribd.com/doc/17223077/Program-Development-and-Integrated-Treatment-Across-Systems-for-Dual-Diagnosis-Kathleen-Sciacca","//doi.org/10.1007/bf02522303","http://robertwhitaker.org/robertwhitaker.org/Anatomy%20of%20an%20Epidemic.html","http://knowledgeisnecessity.blogspot.com/2010/11/supersensitivity-psychosis-evidence.html","http://www.ahrp.org/risks/biblio0100.php","http://breggin.com/index.php?option=com_docman&task=doc_download&gid=232&Itemid=37","http://www.rcpsych.ac.uk","https://www.scribd.com/doc/52145406/Integrated-group-treatment-for-people-experiencing-mental-health%E2%80%93substance-use-problems-Kathleen-Sciacca","https://www.scribd.com/doc/17222954/The-Family-and-the-Dually-Diagnosed-Patient-Kathleen-Sciacca","http://users.erols.com/ksciacca/giglioti.htm","//doi.org/10.1176/appi.ajp.163.4.689","http://motivationalinterviewingtraining.com/uploads/scan_1_HelpfullPeopleInTouchChapt..pdf"],"sections":[{"toclevel":1,"level":"2","line":"Differentiating pre-existing and substance induced","number":"1","index":"1","fromtitle":"Dual_diagnosis","byteoffset":2254,"anchor":"Differentiating_pre-existing_and_substance_induced"},{"toclevel":1,"level":"2","line":"Prevalence","number":"2","index":"2","fromtitle":"Dual_diagnosis","byteoffset":6058,"anchor":"Prevalence"},{"toclevel":1,"level":"2","line":"Diagnosis","number":"3","index":"3","fromtitle":"Dual_diagnosis","byteoffset":10650,"anchor":"Diagnosis"},{"toclevel":1,"level":"2","line":"Treatment","number":"4","index":"4","fromtitle":"Dual_diagnosis","byteoffset":11166,"anchor":"Treatment"},{"toclevel":1,"level":"2","line":"Theories of dual diagnosis","number":"5","index":"5","fromtitle":"Dual_diagnosis","byteoffset":17076,"anchor":"Theories_of_dual_diagnosis"},{"toclevel":2,"level":"3","line":"Causality","number":"5.1","index":"6","fromtitle":"Dual_diagnosis","byteoffset":17534,"anchor":"Causality"},{"toclevel":2,"level":"3","line":"Attention-deficit hyperactivity disorder","number":"5.2","index":"7","fromtitle":"Dual_diagnosis","byteoffset":20431,"anchor":"Attention-deficit_hyperactivity_disorder"},{"toclevel":2,"level":"3","line":"Autism spectrum disorder","number":"5.3","index":"8","fromtitle":"Dual_diagnosis","byteoffset":22527,"anchor":"Autism_spectrum_disorder"},{"toclevel":2,"level":"3","line":"Gambling","number":"5.4","index":"9","fromtitle":"Dual_diagnosis","byteoffset":24305,"anchor":"Gambling"},{"toclevel":2,"level":"3","line":"Past exposure to psychiatric medications theory","number":"5.5","index":"10","fromtitle":"Dual_diagnosis","byteoffset":24954,"anchor":"Past_exposure_to_psychiatric_medications_theory"},{"toclevel":2,"level":"3","line":"Self-medication theory","number":"5.6","index":"11","fromtitle":"Dual_diagnosis","byteoffset":26291,"anchor":"Self-medication_theory"},{"toclevel":2,"level":"3","line":"Alleviation of dysphoria theory","number":"5.7","index":"12","fromtitle":"Dual_diagnosis","byteoffset":28550,"anchor":"Alleviation_of_dysphoria_theory"},{"toclevel":2,"level":"3","line":"Multiple risk factor theory","number":"5.8","index":"13","fromtitle":"Dual_diagnosis","byteoffset":29334,"anchor":"Multiple_risk_factor_theory"},{"toclevel":2,"level":"3","line":"The supersensitivity theory","number":"5.9","index":"14","fromtitle":"Dual_diagnosis","byteoffset":30636,"anchor":"The_supersensitivity_theory"},{"toclevel":1,"level":"2","line":"Avoiding categorical diagnosis","number":"6","index":"15","fromtitle":"Dual_diagnosis","byteoffset":32158,"anchor":"Avoiding_categorical_diagnosis"},{"toclevel":1,"level":"2","line":"History","number":"7","index":"16","fromtitle":"Dual_diagnosis","byteoffset":33285,"anchor":"History"},{"toclevel":1,"level":"2","line":"References","number":"8","index":"17","fromtitle":"Dual_diagnosis","byteoffset":37383,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"9","index":"18","fromtitle":"Dual_diagnosis","byteoffset":37416,"anchor":"Further_reading"}],"parsewarnings":[],"displaytitle":"Dual diagnosis","iwlinks":[{"prefix":"wikt","url":"https://en.wiktionary.org/wiki/imbalance","*":"wikt:imbalance"}],"properties":[{"name":"defaultsort","*":"Dual Diagnosis"},{"name":"wikibase_item","*":"Q2914812"}]}}